{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,5,27]],"date-time":"2025-05-27T21:06:44Z","timestamp":1748380004251},"reference-count":63,"publisher":"Elsevier BV","issue":"17-18","license":[{"start":{"date-parts":[[2004,6,1]],"date-time":"2004-06-01T00:00:00Z","timestamp":1086048000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Vaccine"],"published-print":{"date-parts":[[2004,6]]},"DOI":"10.1016\/j.vaccine.2003.11.047","type":"journal-article","created":{"date-parts":[[2004,5,29]],"date-time":"2004-05-29T14:09:38Z","timestamp":1085839778000},"page":"2171-2180","source":"Crossref","is-referenced-by-count":16,"title":["Immunogenicity and bactericidal activity in mice of an outer membrane protein vesicle vaccine against Neisseria meningitidis serogroup A disease"],"prefix":"10.1016","volume":"22","author":[{"given":"Gunnstein","family":"Norheim","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"E","family":"Arne H\u00f8iby","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Dominique A","family":"Caugant","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ellen","family":"Namork","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Torill","family":"Tangen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Elisabeth","family":"Fritzs\u00f8nn","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Einar","family":"Rosenqvist","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.vaccine.2003.11.047_BIB1","first-page":"3","article-title":"La m\u00e9ningite c\u00e9r\u00e9brospinale en Afrique","volume":"28","author":"Lapeysonnie","year":"1963","journal-title":"Bull. WHO"},{"key":"10.1016\/j.vaccine.2003.11.047_BIB2","doi-asserted-by":"crossref","first-page":"5267","DOI":"10.1128\/IAI.60.12.5267-5282.1992","article-title":"Clonal and antigenic analysis of serogroup A Neisseria meningitidis with particular reference to epidemiological features of epidemic meningitis in the People\u2019s Republic of China","volume":"60","author":"Wang","year":"1992","journal-title":"Infect. Immun."},{"key":"10.1016\/j.vaccine.2003.11.047_BIB3","doi-asserted-by":"crossref","first-page":"186","DOI":"10.1016\/S0966-842X(00)88918-0","article-title":"Epidemic spread and antigenic variability of Neisseria meningitidis","volume":"3","author":"Achtman","year":"1995","journal-title":"Trends Microbiol."},{"key":"10.1016\/j.vaccine.2003.11.047_BIB4","doi-asserted-by":"crossref","first-page":"505","DOI":"10.1111\/j.1699-0463.1998.tb01379.x","article-title":"Population genetics and molecular epidemiology of Neisseria meningitidis","volume":"106","author":"Caugant","year":"1998","journal-title":"APMIS"},{"key":"10.1016\/j.vaccine.2003.11.047_BIB5","doi-asserted-by":"crossref","first-page":"3140","DOI":"10.1073\/pnas.95.6.3140","article-title":"Multilocus sequence typing: a portable approach to the identification of clones within populations of pathogenic microorganisms","volume":"95","author":"Maiden","year":"1998","journal-title":"Proc. Natl. Acad. Sci. U.S.A."},{"key":"10.1016\/j.vaccine.2003.11.047_BIB6","doi-asserted-by":"crossref","first-page":"849","DOI":"10.3201\/eid0705.010513","article-title":"Clonal expansion of sequence type (ST-)5 and emergence of ST-7 in serogroup A meningococci, Africa","volume":"7","author":"Nicolas","year":"2001","journal-title":"Emerg. Infect. Dis."},{"key":"10.1016\/j.vaccine.2003.11.047_BIB7","doi-asserted-by":"crossref","first-page":"665","DOI":"10.1093\/clinids\/9.4.665","article-title":"Clonal population structure of Neisseria meningitidis serogroup A isolated from epidemics and pandemics between 1915 and 1983","volume":"9","author":"Olyhoek","year":"1987","journal-title":"Rev. Infect. Dis."},{"key":"10.1016\/j.vaccine.2003.11.047_BIB8","doi-asserted-by":"crossref","first-page":"5234","DOI":"10.1073\/pnas.061386098","article-title":"Fit genotypes and escape variants of subgroup III Neisseria meningitidis during three pandemics of epidemic meningitis","volume":"98","author":"Zhu","year":"2001","journal-title":"Proc. Natl. Acad. Sci. U.S.A."},{"key":"10.1016\/j.vaccine.2003.11.047_BIB9","doi-asserted-by":"crossref","first-page":"253","DOI":"10.1111\/j.1365-2958.1994.tb01014.x","article-title":"The porA gene in serogroup A meningococci: evolutionary stability and mechanism of genetic variation","volume":"12","author":"Suker","year":"1994","journal-title":"Mol. Microbiol."},{"key":"10.1016\/j.vaccine.2003.11.047_BIB10","first-page":"183","article-title":"Immunoblotting studies of vaccinee and patient sera from the Norwegian serogroup B meningococcal vaccination trial","volume":"14","author":"Wedege","year":"1991","journal-title":"NIPH Ann."},{"key":"10.1016\/j.vaccine.2003.11.047_BIB11","doi-asserted-by":"crossref","first-page":"1367","DOI":"10.1084\/jem.129.6.1367","article-title":"Human immunity to the meningococcus. IV. Immunogenicity of group A and group C meningococcal polysaccharides in human volunteers","volume":"129","author":"Gotschlich","year":"1969","journal-title":"J. Exp. Med."},{"key":"10.1016\/j.vaccine.2003.11.047_BIB12","unstructured":"Patel M, Lee CK. Polysaccharide vaccines for preventing serogroup A meningococcal meningitis (Cochrane Review). In: The Cochrane Library, Issue 4. Chichester, UK: Wiley; 2003."},{"key":"10.1016\/j.vaccine.2003.11.047_BIB13","doi-asserted-by":"crossref","first-page":"1307","DOI":"10.1084\/jem.129.6.1307","article-title":"Human immunity to the meningococcus. I. The role of humoral antibodies","volume":"129","author":"Goldschneider","year":"1969","journal-title":"J. Exp. Med."},{"key":"10.1016\/j.vaccine.2003.11.047_BIB14","doi-asserted-by":"crossref","first-page":"845","DOI":"10.1097\/00006454-200010000-00001","article-title":"A rebuttal\u2014epidemic and endemic meningococcal meningitis in sub-Saharan Africa can be prevented now by routine immunization with group A meningococcal capsular polysaccharide vaccine","volume":"19","author":"Robbins","year":"2000","journal-title":"Pediatr. Infect. Dis. J."},{"key":"10.1016\/j.vaccine.2003.11.047_BIB15","unstructured":"World Health Organisation (Geneva, Switzerland). Meningococcal vaccines: polysaccharide and polysaccharide conjugate vaccines. Wkly Epidemiol Rec 2002;40:331\u20139."},{"key":"10.1016\/j.vaccine.2003.11.047_BIB16","doi-asserted-by":"crossref","first-page":"691","DOI":"10.1016\/0264-410X(92)90091-W","article-title":"Development and phase 1 clinical testing of a conjugate vaccine against meningococcus A and C","volume":"10","author":"Costantino","year":"1992","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2003.11.047_BIB17","doi-asserted-by":"crossref","first-page":"3391","DOI":"10.1128\/IAI.62.8.3391-3395.1994","article-title":"Safety and immunogenicity of meningococcal A and C polysaccharide conjugate vaccine in adults","volume":"62","author":"Anderson","year":"1994","journal-title":"Infect. Immun."},{"key":"10.1016\/j.vaccine.2003.11.047_BIB18","doi-asserted-by":"crossref","first-page":"632","DOI":"10.1093\/infdis\/171.3.632","article-title":"A trial of a group A plus group C meningococcal polysaccharide-protein conjugate vaccine in African infants","volume":"171","author":"Twumasi","year":"1995","journal-title":"J. Infect. Dis."},{"key":"10.1016\/j.vaccine.2003.11.047_BIB19","doi-asserted-by":"crossref","first-page":"1360","DOI":"10.1093\/infdis\/174.6.1360","article-title":"Conjugate meningococcal serogroup A and C vaccine: reactogenicity and immunogenicity in United Kingdom infants","volume":"174","author":"Fairley","year":"1996","journal-title":"J. Infect. Dis."},{"key":"10.1016\/j.vaccine.2003.11.047_BIB20","doi-asserted-by":"crossref","first-page":"1499","DOI":"10.1001\/jama.275.19.1499","article-title":"Safety and immunogenicity of a serogroups A\/C Neisseria meningitidis oligosaccharide-protein conjugate vaccine in young children. A randomized controlled trial","volume":"275","author":"Lieberman","year":"1996","journal-title":"JAMA"},{"key":"10.1016\/j.vaccine.2003.11.047_BIB21","doi-asserted-by":"crossref","first-page":"144","DOI":"10.1097\/00006454-200002000-00013","article-title":"Safety and immunogenicity of three doses of a Neisseria meningitidis A + C diphtheria conjugate vaccine in infants from Niger","volume":"19","author":"Campagne","year":"2000","journal-title":"Pediatr. Infect. Dis. J."},{"key":"10.1016\/j.vaccine.2003.11.047_BIB22","doi-asserted-by":"crossref","first-page":"1142","DOI":"10.1086\/368358","article-title":"Immunogenicity and immunological priming of the serogroup A portion of a bivalent meningococcal A\/C conjugate vaccine in 2-year-old children","volume":"187","author":"Joseph","year":"2003","journal-title":"J. Infect. Dis."},{"key":"10.1016\/j.vaccine.2003.11.047_BIB23","doi-asserted-by":"crossref","first-page":"3402","DOI":"10.1128\/IAI.71.6.3402-3408.2003","article-title":"Disparity in functional activity between serum anticapsular antibodies induced in adults by immunization with an investigational group A and C Neisseria meningitidis-diphtheria toxoid conjugate vaccine and by a polysaccharide vaccine","volume":"71","author":"Harris","year":"2003","journal-title":"Infect. Immun."},{"key":"10.1016\/j.vaccine.2003.11.047_BIB24","doi-asserted-by":"crossref","first-page":"200","DOI":"10.1093\/infdis\/175.1.200","article-title":"Induction of immunologic memory in Gambian children by vaccination in infancy with a group A plus group C meningococcal polysaccharide-protein conjugate vaccine","volume":"175","author":"Leach","year":"1997","journal-title":"J. Infect. Dis."},{"key":"10.1016\/j.vaccine.2003.11.047_BIB25","doi-asserted-by":"crossref","first-page":"661","DOI":"10.1086\/322790","article-title":"Meningococcal serogroup A avidity indices as a surrogate marker of priming for the induction of immunologic memory after vaccination with a meningococcal A\/C conjugate vaccine in infants in the United Kingdom","volume":"184","author":"Joseph","year":"2001","journal-title":"J. Infect. Dis."},{"key":"10.1016\/j.vaccine.2003.11.047_BIB26","doi-asserted-by":"crossref","first-page":"1902","DOI":"10.1016\/S0140-6736(03)13494-0","article-title":"Meningococcal conjugate vaccine for Africa: a model for development of new vaccines for the poorest countries","volume":"361","author":"Jodar","year":"2003","journal-title":"Lancet"},{"key":"10.1016\/j.vaccine.2003.11.047_BIB27","first-page":"195","article-title":"Vaccine against group B Neisseria meningitidis: protection trial and mass vaccination results in Cuba","volume":"14","author":"Sierra","year":"1991","journal-title":"NIPH Ann."},{"key":"10.1016\/j.vaccine.2003.11.047_BIB28","doi-asserted-by":"crossref","first-page":"1093","DOI":"10.1016\/0140-6736(91)91961-S","article-title":"Effect of outer membrane vesicle vaccine against group B meningococcal disease in Norway","volume":"338","author":"Bjune","year":"1991","journal-title":"Lancet"},{"key":"10.1016\/j.vaccine.2003.11.047_BIB29","doi-asserted-by":"crossref","first-page":"4642","DOI":"10.1128\/IAI.63.12.4642-4652.1995","article-title":"Human antibody responses to meningococcal outer membrane antigens after three doses of the Norwegian group B meningococcal vaccine","volume":"12","author":"Rosenqvist","year":"1995","journal-title":"Infect. Immun."},{"key":"10.1016\/j.vaccine.2003.11.047_BIB30","doi-asserted-by":"crossref","first-page":"1074","DOI":"10.1016\/0140-6736(92)93086-3","article-title":"Protective efficacy of a serogroup B meningococcal vaccine in Sao Paulo, Brazil","volume":"340","author":"de Moraes","year":"1992","journal-title":"Lancet"},{"key":"10.1016\/j.vaccine.2003.11.047_BIB31","doi-asserted-by":"crossref","first-page":"683","DOI":"10.1086\/514232","article-title":"Immunogenicity of two efficacious outer membrane protein-based serogroup B meningococcal vaccines among young adults in Iceland","volume":"3","author":"Perkins","year":"1998","journal-title":"J. Infect. Dis."},{"key":"10.1016\/j.vaccine.2003.11.047_BIB32","doi-asserted-by":"crossref","first-page":"1520","DOI":"10.1001\/jama.281.16.1520","article-title":"Immunogenicity of 2 serogroup B outer membrane protein meningococcal vaccines\u2014a randomized controlled trial in Chile","volume":"281","author":"Tappero","year":"1999","journal-title":"JAMA"},{"key":"10.1016\/j.vaccine.2003.11.047_BIB33","doi-asserted-by":"crossref","first-page":"734","DOI":"10.1016\/S0264-410X(02)00591-1","article-title":"Serum bactericidal activity correlates with the vaccine efficacy of outer membrane vesicle vaccines against Neisseria meningitidis serogroup B disease","volume":"21","author":"Holst","year":"2003","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2003.11.047_BIB34","first-page":"030724","article-title":"A \u2018tailor made\u2019 vaccine trialled as part of public health response to group B meningococcal epidemic in New Zealand","volume":"7","author":"Holst","year":"2003","journal-title":"Eurosurveillance Wkly"},{"key":"10.1016\/j.vaccine.2003.11.047_BIB35","first-page":"67","article-title":"Production, characterization and control of MenB-vaccine \u201cFolkehelsa\u201d: an outer membrane vesicle vaccine against group B meningococcal disease","volume":"14","author":"Fredriksen","year":"1991","journal-title":"NIPH Ann."},{"key":"10.1016\/j.vaccine.2003.11.047_BIB36","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1099\/00222615-31-3-195","article-title":"Serotyping and subtyping of Neisseria meningitidis isolates by coagglutination","volume":"31","author":"Wedege","year":"1990","journal-title":"J. Med. Microbiol."},{"key":"10.1016\/j.vaccine.2003.11.047_BIB37","doi-asserted-by":"crossref","first-page":"1267","DOI":"10.1128\/IAI.67.3.1267-1276.1999","article-title":"Functional activities and epitope specificity of human and murine antibodies against the class 4 outer membrane protein (Rmp) of Neisseria meningitidis","volume":"67","author":"Rosenqvist","year":"1999","journal-title":"Infect. Immun."},{"key":"10.1016\/j.vaccine.2003.11.047_BIB38","doi-asserted-by":"crossref","unstructured":"Wedege E. Immunoblot analysis of sera from patients and vaccinees. In: Pollard AJ, Maiden MCJ, editors. Methods in molecular medicine. Meningococcal vaccines. Methods and protocols. Totowa, NJ: Humana Press; 2001. p. 275\u201388.","DOI":"10.1385\/1-59259-148-5:275"},{"key":"10.1016\/j.vaccine.2003.11.047_BIB39","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1016\/0092-1157(89)90017-6","article-title":"Measurements of lipopolysaccharide (endotoxin) in meningococcal protein and polysaccharide preparations for vaccine usage","volume":"17","author":"Tsai","year":"1989","journal-title":"J. Biol. Stand."},{"key":"10.1016\/j.vaccine.2003.11.047_BIB40","doi-asserted-by":"crossref","unstructured":"Rosenqvist E, K\u00e4yhty H, Pollard AJ. Determination of antibody responses to meningococcal antigens by ELlSA. In: Pollard AJ, Maiden MCJ, editors. Methods in molecular medicine. Meningococcal vaccines. Methods and protocols. Totowa, NJ: Humana Press; 2001. p. 255\u201373.","DOI":"10.1385\/1-59259-148-5:255"},{"key":"10.1016\/j.vaccine.2003.11.047_BIB41","first-page":"147","article-title":"Bactericidal antibodies after vaccination with the Norwegian meningococcal serogroup B outer membrane vesicle vaccine; a brief survey","volume":"14","author":"H\u00f8iby","year":"1991","journal-title":"NIPH Ann."},{"key":"10.1016\/j.vaccine.2003.11.047_BIB42","doi-asserted-by":"crossref","first-page":"257","DOI":"10.1128\/IAI.40.1.257-264.1983","article-title":"Importance of complement source in bactericidal activity of human antibody and murine monoclonal antibody to meningococcal group B polysaccharide","volume":"40","author":"Zollinger","year":"1983","journal-title":"Infect Immun"},{"key":"10.1016\/j.vaccine.2003.11.047_BIB43","doi-asserted-by":"crossref","first-page":"1486","DOI":"10.1128\/JCM.29.7.1486-1492.1991","article-title":"Characterization of serogroup A and B strains of Neisseria meningitidis with serotype 4 and 21 monoclonal antibodies and by multilocus enzyme electrophoresis","volume":"29","author":"Wedege","year":"1991","journal-title":"J. Clin. Microbiol."},{"key":"10.1016\/j.vaccine.2003.11.047_BIB44","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1093\/infdis\/165.1.53","article-title":"A comparison of the variable antigens expressed by clone IV-1 and subgroup III of Neisseria meningitidis serogroup A","volume":"165","author":"Achtman","year":"1992","journal-title":"J. Infect. Dis."},{"key":"10.1016\/j.vaccine.2003.11.047_BIB45","doi-asserted-by":"crossref","first-page":"390","DOI":"10.1128\/CDLI.7.3.390-395.2000","article-title":"Sequence variation in the porA gene of a clone of Neisseria meningitidis during epidemic spread","volume":"7","author":"Jelfs","year":"2000","journal-title":"Clin. Diagn. Lab. Immunol."},{"key":"10.1016\/j.vaccine.2003.11.047_BIB46","doi-asserted-by":"crossref","first-page":"841","DOI":"10.1046\/j.1365-2958.1996.437970.x","article-title":"Allelic polymorphism and site-specific recombination in the opc locus of Neisseria meningitidis","volume":"19","author":"Seiler","year":"1996","journal-title":"Mol. Microbiol."},{"key":"10.1016\/j.vaccine.2003.11.047_BIB47","doi-asserted-by":"crossref","first-page":"1711","DOI":"10.1128\/JCM.28.8.1711-1719.1990","article-title":"Characterization of epidemic and nonepidemic Neisseria meningitidis serogroup A strains from Sudan and Sweden","volume":"28","author":"Salih","year":"1990","journal-title":"J. Clin. Microbiol."},{"key":"10.1016\/j.vaccine.2003.11.047_BIB48","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1111\/j.1365-2958.1994.tb00416.x","article-title":"Variable expression of the Opc outer membrane protein in Neisseria meningitidisis caused by size variation of a promoter containing poly-cytidine","volume":"13","author":"Sarkari","year":"1994","journal-title":"Mol. Microbiol."},{"key":"10.1016\/j.vaccine.2003.11.047_BIB49","doi-asserted-by":"crossref","first-page":"375","DOI":"10.1093\/infdis\/164.2.375","article-title":"Variation in Class 5 protein expression by serogroup A meningococci during a meningitis epidemic","volume":"164","author":"Achtman","year":"1991","journal-title":"J. Infect. Dis."},{"key":"10.1016\/j.vaccine.2003.11.047_BIB50","doi-asserted-by":"crossref","first-page":"1566","DOI":"10.1128\/IAI.62.5.1566-1575.1994","article-title":"Meningococcal group A lipooligosaccharides (LOS): preliminary structural studies and characterization of serotype-associated and conserved LOS epitopes","volume":"62","author":"Kim","year":"1994","journal-title":"Infect. Immun."},{"key":"10.1016\/j.vaccine.2003.11.047_BIB51","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1111\/j.1574-6968.2001.tb10837.x","article-title":"Genetic analysis of conservation and variation of lipooligosaccharide expression in two L8-immunotype strains of Neisseria meningitidis","volume":"203","author":"Zhu","year":"2001","journal-title":"FEMS Microbiol. Lett."},{"key":"10.1016\/j.vaccine.2003.11.047_BIB52","doi-asserted-by":"crossref","first-page":"1327","DOI":"10.1016\/S0264-410X(00)00333-9","article-title":"Development of natural immunity to Neisseria meningitidis","volume":"19","author":"Pollard","year":"2001","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2003.11.047_BIB53","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1016\/S0264-410X(96)00138-7","article-title":"Persistence of antibodies to meningococcal IgA1 protease versus decay of antibodies to group A polysaccharide and Opc protein","volume":"15","author":"Thiesen","year":"1997","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2003.11.047_BIB54","doi-asserted-by":"crossref","first-page":"3762","DOI":"10.1128\/IAI.69.6.3762-3771.2001","article-title":"Functional activity of anti-neisserial surface protein A monoclonal antibodies against strains of Neisseria meningitidis serogroup B","volume":"69","author":"Moe","year":"2001","journal-title":"Infect. Immun."},{"key":"10.1016\/j.vaccine.2003.11.047_BIB55","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1128\/IAI.65.1.55-63.1997","article-title":"Evaluation of recombinant transferrin-binding protein B variants from Neisseria meningitidis for their ability to induce cross-reactive and bactericidal antibodies against a genetically diverse collection of serogroup B strains","volume":"65","author":"Rokbi","year":"1997","journal-title":"Infect. Immun."},{"key":"10.1016\/j.vaccine.2003.11.047_BIB56","doi-asserted-by":"crossref","first-page":"1526","DOI":"10.1016\/S0264-410X(00)00324-8","article-title":"PorB3 outer membrane protein on Neisseria meningitidis is poorly accessible for antibody binding on live bacteria","volume":"19","author":"Michaelsen","year":"2001","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2003.11.047_BIB57","doi-asserted-by":"crossref","first-page":"4028","DOI":"10.1128\/IAI.70.8.4028-4034.2002","article-title":"Immunization with the recombinant PorB outer membrane protein induces a bactericidal immune response against Neisseria meningitidis","volume":"70","author":"Wright","year":"2002","journal-title":"Infect. Immun."},{"key":"10.1016\/j.vaccine.2003.11.047_BIB58","doi-asserted-by":"crossref","first-page":"1533","DOI":"10.1128\/JB.180.6.1533-1539.1998","article-title":"Characterization of the gene cassette required for biosynthesis of the (alpha1\u21926)-linked N-acetyl-d-mannosamine-1-phosphate capsule of serogroup A Neisseria meningitidis","volume":"180","author":"Swartley","year":"1998","journal-title":"J. Bacteriol."},{"key":"10.1016\/j.vaccine.2003.11.047_BIB59","doi-asserted-by":"crossref","first-page":"6685","DOI":"10.1128\/IAI.68.12.6685-6690.2000","article-title":"Multiple mechanisms of phase variation of PorA in Neisseria meningitidis","volume":"68","author":"van der Ende","year":"2000","journal-title":"Infect. Immun."},{"key":"10.1016\/j.vaccine.2003.11.047_BIB60","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1128\/CDLI.2.1.69-72.1995","article-title":"Serotypes and subtypes of Neisseria meningitidis: results of an international study comparing sensitivities and specificities of monoclonal antibodies","volume":"2","author":"Poolman","year":"1995","journal-title":"Clin. Diagn. Lab. Immunol."},{"key":"10.1016\/j.vaccine.2003.11.047_BIB61","doi-asserted-by":"crossref","first-page":"1065","DOI":"10.1093\/infdis\/167.5.1065","article-title":"The 5C protein of Neisseria meningitidis is highly immunogenic in humans and induces bactericidal antibodies","volume":"167","author":"Rosenqvist","year":"1993","journal-title":"J. Infect. Dis."},{"key":"10.1016\/j.vaccine.2003.11.047_BIB62","doi-asserted-by":"crossref","first-page":"236","DOI":"10.1099\/00222615-41-4-236","article-title":"Lipo-oligosaccharide immunotyping of Neisseria meningitidis by a whole-cell ELISA with monoclonal antibodies","volume":"41","author":"Scholten","year":"1994","journal-title":"J. Med. Microbiol."},{"key":"10.1016\/j.vaccine.2003.11.047_BIB63","doi-asserted-by":"crossref","first-page":"5290","DOI":"10.1128\/IAI.62.12.5290-5295.1994","article-title":"Expression of the L8 lipopolysaccharide determinant increases the sensitivity of Neisseria meningitidis to serum bactericidal activity","volume":"62","author":"Moran","year":"1994","journal-title":"Infect. Immun."}],"container-title":["Vaccine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X0300848X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X0300848X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2020,4,2]],"date-time":"2020-04-02T09:02:03Z","timestamp":1585818123000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0264410X0300848X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2004,6]]},"references-count":63,"journal-issue":{"issue":"17-18","published-print":{"date-parts":[[2004,6]]}},"alternative-id":["S0264410X0300848X"],"URL":"https:\/\/doi.org\/10.1016\/j.vaccine.2003.11.047","relation":{},"ISSN":["0264-410X"],"issn-type":[{"value":"0264-410X","type":"print"}],"subject":[],"published":{"date-parts":[[2004,6]]}}}